Transanal minimally-invasive surgery (TAMIS): experience with no closure of the rectal defect

Background: In transanalminimally-invasive surgery (TAMIS), the closure of the rectal defect is controversial, and endoluminal suture is one of the most challenging aspects. The goal of the present study is to evaluate the short- andmedium-term complications of a consecutive series of patients with extraperitoneal rectal injuries who underwent TAMIS without closure of the rectal defect. Materials and Methods: A prospective, longitudinal, descriptive study conducted between August 2013 and July 2019 in which all patients with extraperitoneal rectal lesions, who were operated on using the TAMIS technique, were consecutively included. The lesions were: benign lesions ≥ 3 cm; neuroendocrine tumors ≤ 2 cm; adenocarcinomas in stage T1N0; and adenocarcinomas in stage T2N0, with high surgical risk, or with the patients reluctant to undergo radical surgery, and others with doubts about complete remission after the neoadjuvant therapy. Bleeding, infectious complications, rectal stenosis, perforations, and death were evaluated. Results: A total of 35 patients were treated using TAMIS without closure of the defect. The average size of the lesionswas of 3.68±2.1 cm(95% confidence interval [95%CI]: 0.7cmto 9 cm), their average distance from the anal margin was of 5.7±1.48cm, and the average operative time was of 39.2±20.5 minutes, with a minimum postoperative follow-up of 1 year. As for the pathologies, they were: 15 adenomas; 3 carcinoid tumors; and 17 adenocarcinomas. In all cases, the rectal defect was left open. The overall morbidity was of 14.2%. Two patients (grade II in the Clavien-Dindo classification) were readmitted for pain treatment, and three patients (grade III in the Clavien-Dindo classification) were assisted due to postoperative bleeding, one of whom required reoperation. Conclusion: The TAMIS technique without closure of the rectal defect yields good results, and present a high feasibility and low complication rate. (AU)

[Neoplasic colonic obstruction: resolution with self-expanding metallic stents]. / Obstrucción neoplásica de colon: tratamiento con prótesis autoexpansibles.

INTRODUCTION: The endoscopic placement of self-expanding metallic stents (SEMS) emerges as a therapeutic option for neoplastic colonic obstruction in two situations: as palliative treatment and as a bridge to surgery. The latter can avoid emergency surgery, thus decreasing the rate of ostomies and the mortality and morbidity associated with them. OBJECTIVES: To evaluate the feasibility, safety and benefits of SEMS placement for the treatment of neoplastic colorectal obstruction. MATERIALS AND METHODS: Between August 2008 and June 2012, we included in this prospective, longitudinal, descriptive and observational study all the patients suffering from colorectal neoplasia who were subjected to SEMS placement by the same group ofendoscopists. Nitinol SEMS were inserted under endoscopic vision and radioscopic control. RESULTS: Twenty seven SEMS were inserted in 27 patients, 61% of them were male and the average age was 70 years old. Symptoms of colonic suboclussion or obstruction were found in 92% of patients, 88% of the lesions were located in the left-side colon, 41% of cases were performed on an ambulatory basis and 65% of stenting was carried out for palliative purposes. The average time of hospitalization was 6,46 days. Technical and clinical success were 93% and 100%, respectively. Minor complications were observed in 11% of patients. Colonic stenting was followed by elective surgery within one month, by a laparoscopic technique in most cases. CONCLUSION: The placement of SEMS arises as a safe and effective alternative to palliative surgery or as a bridge to elective surgery.

Obstrucción neoplásica de colon: tratamiento con prótesis autoexpansibles / [Neoplasic colonic obstruction: resolution with self-expanding metallic stents].

INTRODUCTION: The endoscopic placement of self-expanding metallic stents (SEMS) emerges as a therapeutic option for neoplastic colonic obstruction in two situations: as palliative treatment and as a bridge to surgery. The latter can avoid emergency surgery, thus decreasing the rate of ostomies and the mortality and morbidity associated with them. OBJECTIVES: To evaluate the feasibility, safety and benefits of SEMS placement for the treatment of neoplastic colorectal obstruction. MATERIALS AND METHODS: Between August 2008 and June 2012, we included in this prospective, longitudinal, descriptive and observational study all the patients suffering from colorectal neoplasia who were subjected to SEMS placement by the same group ofendoscopists. Nitinol SEMS were inserted under endoscopic vision and radioscopic control. RESULTS: Twenty seven SEMS were inserted in 27 patients, 61

of them were male and the average age was 70 years old. Symptoms of colonic suboclussion or obstruction were found in 92

of the lesions were located in the left-side colon, 41

of cases were performed on an ambulatory basis and 65

of stenting was carried out for palliative purposes. The average time of hospitalization was 6,46 days. Technical and clinical success were 93

, respectively. Minor complications were observed in 11

of patients. Colonic stenting was followed by elective surgery within one month, by a laparoscopic technique in most cases. CONCLUSION: The placement of SEMS arises as a safe and effective alternative to palliative surgery or as a bridge to elective surgery.

Obstrucción neoplásica de colon: tratamiento con prótesis autoexpansibles. / [Neoplasic colonic obstruction: resolution with self-expanding metallic stents].

INTRODUCTION: The endoscopic placement of self-expanding metallic stents (SEMS) emerges as a therapeutic option for neoplastic colonic obstruction in two situations: as palliative treatment and as a bridge to surgery. The latter can avoid emergency surgery, thus decreasing the rate of ostomies and the mortality and morbidity associated with them. OBJECTIVES: To evaluate the feasibility, safety and benefits of SEMS placement for the treatment of neoplastic colorectal obstruction. MATERIALS AND METHODS: Between August 2008 and June 2012, we included in this prospective, longitudinal, descriptive and observational study all the patients suffering from colorectal neoplasia who were subjected to SEMS placement by the same group ofendoscopists. Nitinol SEMS were inserted under endoscopic vision and radioscopic control. RESULTS: Twenty seven SEMS were inserted in 27 patients, 61

of them were male and the average age was 70 years old. Symptoms of colonic suboclussion or obstruction were found in 92

of patients, 88

of the lesions were located in the left-side colon, 41

of cases were performed on an ambulatory basis and 65

of stenting was carried out for palliative purposes. The average time of hospitalization was 6,46 days. Technical and clinical success were 93

and 100

, respectively. Minor complications were observed in 11

of patients. Colonic stenting was followed by elective surgery within one month, by a laparoscopic technique in most cases. CONCLUSION: The placement of SEMS arises as a safe and effective alternative to palliative surgery or as a bridge to elective surgery.